What's Rochelle Hanley's mailing address?
Rochelle's mailing address filed with the SEC is C/O VIKING THERAPEUTICS, INC., 11119 NORTH TORREY PINES ROAD, SUITE 50, SAN DIEGO, CA, 92037.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Viking Therapeutics Inc
Over the last 10 years, insiders at Viking Therapeutics Inc have traded over $46,107,976 worth of Viking Therapeutics Inc stock and bought 199,715 units worth $855,627 . The most active insiders traders include Brian Lian, Charles A Jr Rowland, and Marianna Mancini. On average, Viking Therapeutics Inc executives and independent directors trade stock every 75 days with the average trade being worth of $4,137,170. The most recent stock trade was executed by Brian Lian on 21 August 2024, trading 1,000 units of VKTX stock currently worth $7,770.
What does Viking Therapeutics Inc's logo look like?
Viking Therapeutics Inc executives and stock owners
Viking Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Brian Lian,
President, Chief Executive Officer, Director -
Dr. Brian Lian Ph.D.,
Pres, CEO & Director -
Michael Morneau,
Vice President - Finance and Administration -
S. Kathy Rouan,
Independent Director -
Lawson Macartney,
Independent Chairman of the Board -
Charles Rowland,
Independent Director -
J. Matthew Singleton,
Independent Director -
Matthew Foehr,
Director -
Greg Zante,
Senior Vice President - Finance, IR Contact Officer -
Michael Morneau,
VP of Fin. & Admin. -
Marianne Mancini,
Chief Operating Officer -
Gregory S. Zante,
Chief Financial Officer -
Pharmaceuticals Inc Ligand,
10% owner -
Stephen W Webster,
Director -
Rochelle Hanley,
Chief Medical Officer -
Hiroko Masamune,
Chief Development Officer -
Marianna Mancini,
Chief Operating Officer -
Michael Dinerman,
Chief Operating Officer